Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

1.32
0.0000
Post-market: 1.31-0.0100-0.76%19:30 EDT
Volume:233.27K
Turnover:301.54K
Market Cap:59.47M
PE:-4.26
High:1.33
Open:1.30
Low:1.25
Close:1.32
52wk High:1.51
52wk Low:0.7006
Shares:45.05M
Float Shares:39.17M
Volume Ratio:0.32
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3096
EPS(LYR):-0.3161
ROE:-125.23%
ROA:-64.90%
PB:6.62
PE(LYR):-4.18

Loading ...

RenovoRx regains compliance with Nasdaq

TIPRANKS
·
Aug 21

RenovoRx Regains Compliance with NASDAQ Minimum Bid Price Requirement

THOMSON REUTERS
·
Aug 21

RenovoRx Earnings Call: Record Growth, Rising Risks

TIPRANKS
·
Aug 21

RenovoRx Regains NASDAQ Compliance with $1 Minimum Bid Price Rule

Reuters
·
Aug 21

RenovoRx Gets USPTO Notice of Allowance for New RenovoCath Cancer Drug-Delivery Patent

Reuters
·
Aug 20

RenovoRx - Receives Uspto Notice of Allowance for Renovocath Patent Application

THOMSON REUTERS
·
Aug 20

Analyst Justin Walsh Reiterates Buy on RenovoRx After Strong 2Q26 Beat, Guidance Raise and Confirms $8 Price Target on TAMP Platform Momentum

TIPRANKS
·
Aug 20

Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive

Reuters
·
Aug 15

Milestone Scientific Q2 Revenue Rises 22% on Medical Segment Growth, Reaffirms 2026 Outlook

Reuters
·
Aug 14

Sensus Healthcare Q2 Revenue Misses Estimates as Unit Sales Fall

Reuters
·
Aug 14

CapsoVision Q2 Revenue Rises on CapsoCam Plus Capsules Sales

Reuters
·
Aug 14

Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume

Reuters
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook

Reuters
·
Aug 13

Sweden's RaySearch Q2 Order Intake Rises on Clinical Adoption

Reuters
·
Aug 13

RenovoRx Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

RenovoRx Q2 Adj. EPS $(0.05) Beats $(0.07) Estimate, Sales $909.000K Beat $716.500K Estimate

Benzinga Earnings
·
Aug 13

RenovoRx Q2 Net Loss Holds at $2.91 Million; Revenue More than Doubled to $909,000 Year over Year

Reuters
·
Aug 13

RenovoRx Q2 Net Income USD -2.911 Million

Reuters
·
Aug 13